Previous
Previous

NEUROKININ RECEPTOR ANTAGONISTS AS POTENTIAL NON-HORMONAL TREATMENTS FOR VASOMOTOR SYMPTOMS OF MENOPAUSE

Next
Next

PREIMPLANTATION GENETIC TESTING FOR SICKLE CELL DISEASE – A COST EFFECTIVENESS ANALYSIS (IN PRESS)